Featured content in this Issue:
- Fluence and UPRA Team Up to Bring Psychedelic Therapy Training to Ukraine
- MindBio’s Small Open Label Microdosing Study Shows Promise in MDD
- Biomind’s 5-MeO-DMT Study Shows Promise, But Small Sample and Unclear Protocol Temper Excitement
- Oregon Psilocybin Services Complaints
- Further Reading & Other Stories
Companies, organisations and drug candidates mentioned in this Bulletin: Fluence, Ukrainian Psychedelic Research Association, Heal Ukraine Trauma, MAPS, MindBio, MB22001, Biomind, BMND08, atai Life Sciences; VLS-01; Nue Life Health.
This content is for Pα+ Subscribers
This is the first issue of our Psychedelic Bulletin that’s exclusively for Pα+ subscribers. Head to our Join page to learn more, or sign in to your account.
